• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Imaging and Intervention

Poly-L-lysine-coated catheters are safe and well-tolerated in adults requiring short-term catheterization

byAlex XiangandSimon Pan
February 20, 2026
in Imaging and Intervention, Infectious Disease, Urology
Reading Time: 2 mins read
Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants
Share on FacebookShare on TwitterShare on LinkedIn

1. Poly-L-lysine (PLL)-coated catheters are well-tolerated, safe, and noninferior in preventing bacteriuria compared to noble metal alloys (NMA)-coated catheters in adults requiring short-term catheterization.

Evidence Rating Level: 1 (Excellent)

Catheter-associated urinary tract infections (CAUTI) account for approximately 40% of all nosocomial infections, leading to greater morbidity, extended hospital stays, and increased healthcare costs. Antibiotic- or silver-coated catheters have been shown to reduce rates of CAUTI, with NMA (consisting of gold, silver, and palladium) coated catheters being the most studied. This prospective, multi-centre, randomized controlled noninferiority trial sought to assess the efficacy and safety of a newly developed catheter coated with antimicrobial PLL in reducing the risk of bacteriuria compared to NMA-coated catheters. 300 patients who required indwelling catheterization for at least 24 hours were randomized to receive either PLL (n = 150; mean [SD] age, 57.6 [13.2] years; 34.67% female) or NMA (n = 150; mean [SD] age, 58.0 [12.6] years; 32.67% female) catheters. The mean duration of catheterization was 5.2 ± 1.8 days in the PLL group and 5.8 ± 2.7 days in the NMA group. There were 10 cases (6.9%) and 15 cases (10.1%) of catheter-associated bacteriuria in the PLL and NMA groups, respectively, with a difference of − 3.1% (95% CI [− 7.2%, 6.6%], p = 0.3195). 117 patients (78.0%) and 123 patients (82%) in the PLL and NMA groups, respectively, received antibiotics (p = 0.3862). There was a significantly lower proportion of patients in the PLL group experiencing abnormal urine white blood cells (6.2% vs. 12.8%, p = 0.0194). There was no difference in the incidence of adverse events (2.0% vs. 4.0%, p = 0.5011). PLL catheters are well-tolerated, safe, and noninferior in preventing bacteriuria compared with NMA catheters. Further studies with larger sample sizes are needed to confirm these results.

Click here to read the study in BMC Medicine

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

Tags: Antimicrobialbacteriuriainfectious diseaseUrinary Catheterizationurinary tract infection
Previous Post

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

Next Post

2 Minute Medicine Rewind February 23, 2026

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026
Neoplastic tapeworm cells may invade human tissue in immunocompromised hosts
Infectious Disease

Praziquantel (Biltricide) is associated with higher cure rate than albendazole (Zentel) in the treatment of clonorchiasis

July 31, 2026
Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients
Infectious Disease

Delayed initiation of antibiotic therapy is associated with worse outcomes in skin and soft tissue infections

May 22, 2026
Next Post
Many new pediatric asthma cases attributable to obesity

2 Minute Medicine Rewind February 23, 2026

Prenatal antidepressant exposure may increase risk of poor motor development

Prenatal depression and gestational diabetes are associated with increased risk of childhood obesity

Increased risk of stillbirth recurrence after a previous stillbirth

Physicians slightly more likely to die at home or hospice

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • WGS Oncodetect showed higher recurrence sensitivity than WES Oncodetect in colorectal cancer
  • Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants
  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer in interim phase 3 results
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.